Talent Development

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.

Afton Scientific will deepen its roots in Central Virginia with the assistance of a Youngkin-approved grant from the Commonwealth's Development Opportunity Fund.

The Office of the Director of National Intelligence was the catalyst for the institute, with the goal of using next-gen technology to identify potential security threats and protect Americans.

AgroSpheres, developed through Darden's iLab Incubator, highlights how the University's entrepreneurial ecosystem fosters ventures that make a real-world impact.

AgroSpheres, developed through Darden's iLab Incubator, highlights how the University's entrepreneurial ecosystem fosters ventures that make a real-world impact.

The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.

Much of the industry's success wouldn't be possible without the talent that comes out of UVA, which has developed various ways to support researchers.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

Melissa M. Lubin will lead UVA's School of Continuing and Professional Studies (SCPS) as Dean with emphasis on programs that respond to both student and workforce demand.

Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).